Related Experiment Video
Updated: Jun 13, 2026
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Review of medical and surgical management of Clostridium difficile infection
B Faris1, A Blackmore, N Haboubi
1Department of Microbiology, Trafford Healthcare Trust, Davyhulme, Manchester, M41 5SL, UK.
Abstract:
Clostridium difficile infection (CDI) has become an important area in our daily clinical practice. C. difficile is known to cause a broad spectrum of conditions ranging from asymptomatic carriage, through mild or moderately severe disease with watery diarrhoea, to the life-threatening pseudomembranous colitis (PMC), with toxic megacolon and ileus. Peoples who have been treated with broad-spectrum antibiotics, patients with serious underlying co-morbidities and the elderly are at greatest risk. Over 80% of CDIs reported are in people aged over 65. Due to the alarming increase in its frequency, appearance of more virulent strains and occasional need for life-saving surgical intervention, a more coherent multidisciplinary approach is needed. Combination of rapid turn round time and accurate diagnosis will result in a better management of CDI and a timely implementation of infection control measure. Discontinuation of causative agents such as antibiotic treatment is often curative. In more serious cases, oral administration of metronidazole or vancomycin is the treatment of choice. Relapses of CDI have been reported in about 20-25% of cases, this may increase to 45-60% after the first recurrence. Patients should be treated as soon as possible when the diagnosis of Clostridium difficile colitis is made to avoid sepsis or bowel perforation. Colectomy may improve the outcome of the patient with systemic or complicated Clostridium difficile colitis. This article reviews the changing epidemiological picture, microbiology, histopathology and both medical and surgical managements.
Insights
Clostridium difficile infection (CDI) is a growing concern, especially in the elderly. Prompt diagnosis and multidisciplinary management are crucial for effective treatment and infection control.
Area of Science:
- Infectious Diseases
- Gastroenterology
- Microbiology
Background:
- Clostridium difficile infection (CDI) presents a spectrum of illness, from asymptomatic carriage to life-threatening pseudomembranous colitis.
- Elderly patients, those with co-morbidities, and individuals on broad-spectrum antibiotics are at highest risk for CDI.
- Increasing frequency, virulent strains, and surgical needs necessitate a coordinated multidisciplinary approach to CDI management.
Purpose of the Study:
- To review the evolving epidemiology of Clostridium difficile infection.
- To discuss the microbiology, histopathology, and management strategies for CDI.
- To highlight the importance of timely diagnosis and infection control for better patient outcomes.
Main Methods:
- Review of current literature on Clostridium difficile infection.
- Analysis of epidemiological trends and risk factors.
- Synthesis of medical and surgical treatment modalities.
Main Results:
- CDI affects a broad range of patients, with over 80% of cases in individuals over 65.
- Discontinuation of inciting antibiotics is often curative; metronidazole or vancomycin are standard treatments for severe cases.
- Relapse rates range from 20-25%, increasing significantly after the first recurrence. Surgical intervention may be necessary for complicated cases.
Conclusions:
- Accurate and rapid diagnosis of CDI is essential for timely management and infection control.
- A multidisciplinary approach is vital to address the increasing challenges posed by Clostridium difficile infection.
- Early treatment and appropriate interventions, including surgery when indicated, can improve outcomes for patients with severe or complicated CDI.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...